文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

基于人工智能的病理学预测癌症未知原发灶的起源。

AI-based pathology predicts origins for cancers of unknown primary.

机构信息

Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Cancer Program, Broad Institute of Harvard and MIT, Cambridge, MA, USA.

出版信息

Nature. 2021 Jun;594(7861):106-110. doi: 10.1038/s41586-021-03512-4. Epub 2021 May 5.


DOI:10.1038/s41586-021-03512-4
PMID:33953404
Abstract

Cancer of unknown primary (CUP) origin is an enigmatic group of diagnoses in which the primary anatomical site of tumour origin cannot be determined. This poses a considerable challenge, as modern therapeutics are predominantly specific to the primary tumour. Recent research has focused on using genomics and transcriptomics to identify the origin of a tumour. However, genomic testing is not always performed and lacks clinical penetration in low-resource settings. Here, to overcome these challenges, we present a deep-learning-based algorithm-Tumour Origin Assessment via Deep Learning (TOAD)-that can provide a differential diagnosis for the origin of the primary tumour using routinely acquired histology slides. We used whole-slide images of tumours with known primary origins to train a model that simultaneously identifies the tumour as primary or metastatic and predicts its site of origin. On our held-out test set of tumours with known primary origins, the model achieved a top-1 accuracy of 0.83 and a top-3 accuracy of 0.96, whereas on our external test set it achieved top-1 and top-3 accuracies of 0.80 and 0.93, respectively. We further curated a dataset of 317 cases of CUP for which a differential diagnosis was assigned. Our model predictions resulted in concordance for 61% of cases and a top-3 agreement of 82%. TOAD can be used as an assistive tool to assign a differential diagnosis to complicated cases of metastatic tumours and CUPs and could be used in conjunction with or in lieu of ancillary tests and extensive diagnostic work-ups to reduce the occurrence of CUP.

摘要

原发灶不明癌症(CUP)是一组具有挑战性的诊断,其中肿瘤原发部位无法确定。这是一个很大的挑战,因为现代治疗方法主要针对原发肿瘤。最近的研究集中在使用基因组学和转录组学来确定肿瘤的起源。然而,基因组检测并非总是进行,并且在资源有限的环境中缺乏临床渗透。在这里,为了克服这些挑战,我们提出了一种基于深度学习的算法——通过深度学习评估肿瘤起源(TOAD)——该算法可以使用常规获取的组织学幻灯片提供原发肿瘤起源的鉴别诊断。我们使用具有已知原发起源的肿瘤全切片图像来训练一个模型,该模型可以同时识别肿瘤是原发还是转移,并预测其起源部位。在我们的已知原发起源肿瘤验证集上,该模型的 top-1 准确率为 0.83,top-3 准确率为 0.96,而在我们的外部验证集上,它的 top-1 和 top-3 准确率分别为 0.80 和 0.93。我们进一步整理了一个包含 317 例 CUP 病例的数据集,对这些病例进行了鉴别诊断。我们的模型预测结果与 61%的病例一致,top-3 一致率为 82%。TOAD 可以用作辅助工具,对复杂的转移性肿瘤和 CUP 病例进行鉴别诊断,也可以与辅助检查和广泛的诊断性检查结合使用或替代这些检查,以减少 CUP 的发生。

相似文献

[1]
AI-based pathology predicts origins for cancers of unknown primary.

Nature. 2021-6

[2]
CUP-AI-Dx: A tool for inferring cancer tissue of origin and molecular subtype using RNA gene-expression data and artificial intelligence.

EBioMedicine. 2020-11

[3]
A comparison of DNA sequencing and gene expression profiling to assist tissue of origin diagnosis in cancer of unknown primary.

J Pathol. 2023-1

[4]
Prediction of tumor origin in cancers of unknown primary origin with cytology-based deep learning.

Nat Med. 2024-5

[5]
The practical utility of AI-assisted molecular profiling in the diagnosis and management of cancer of unknown primary: an updated review.

Virchows Arch. 2024-2

[6]
Cancers of unknown primary origin (CUP) are characterized by chromosomal instability (CIN) compared to metastasis of know origin.

BMC Cancer. 2015-3-19

[7]
Development and validation of a gene expression tumour classifier for cancer of unknown primary.

Pathology. 2015-1

[8]
Image-based deep learning model using DNA methylation data predicts the origin of cancer of unknown primary.

Neoplasia. 2024-9

[9]
An integrated tool for determining the primary origin site of metastatic tumours.

J Clin Pathol. 2017-12-16

[10]
Diagnostic work-up of carcinoma of unknown primary: from immunohistochemistry to molecular profiling.

Ann Oncol. 2012-9

引用本文的文献

[1]
Polymerase-based DNA reactions for molecularly computing cancerous diagnostic valences of multiple miRNAs.

J Nanobiotechnology. 2025-9-1

[2]
Intraoperative change in distal motor latency as a predictor for clinical outcome after mini-OCTR: a retrospective cohort study.

Front Neurol. 2025-8-13

[3]
Artificial Intelligence-Based Multimodal Prediction of Postoperative Adjuvant Immunotherapy Benefit in Urothelial Carcinoma: Results From the Phase III, Multicenter, Randomized, IMvigor010 Trial.

MedComm (2020). 2025-8-25

[4]
HistoChat: Instruction-tuning multimodal vision language assistant for colorectal histopathology on limited data.

Patterns (N Y). 2025-5-30

[5]
Advances in nanotechnology-enabled adjuvants for peptide-based cancer vaccines.

Nano Res. 2025-7

[6]
Evolution and integration of artificial intelligence across the cancer continuum in women: advances in risk assessment, prevention, and early detection.

Cancer Causes Control. 2025-8-20

[7]
The value of dual-energy spectral CT in differentiating the pathological grades of T1-size lung adenocarcinoma.

J Thorac Dis. 2025-7-31

[8]
Rethinking cancer of unknown primary: from diagnostic challenge to targeted treatment.

Nat Rev Clin Oncol. 2025-8-4

[9]
Artificial intelligence and machine learning in the development of vaccines and immunotherapeutics-yesterday, today, and tomorrow.

Front Artif Intell. 2025-7-18

[10]
Machine learning approaches for EGFR mutation status prediction in NSCLC: an updated systematic review.

Front Oncol. 2025-7-10

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索